Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36202686.
- Also identified by DOI 10.1016/j.eururo.2022.09.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fluorodeoxyglucose-based positron emission tomography/computed tomography is increasingly being used for staging of muscle-invasive bladder cancer before treatment. However, international clinical guidelines are hesitant to recommend this approach, as conclusive scientific evidence on its usefulness is lacking. The question is whether and how this evidence can be obtained.
Medical subject headings
- Radiopharmaceuticals
- Urinary Bladder Neoplasms